Dividend Information about Encompass Health: Key Dates and Insights Ahead of Oct 1, 2025 Ex-Dividend

Encompass Health (EHC) has announced a cash dividend of $0.19000000 per share, with the ex-dividend date set for Oct 1, 2025. Investors must purchase shares before this date to be eligible for the payout, which will be distributed on Oct 15, 2025. The dividend announcement was made on Jul 24, 2025, following the last cash dividend of $0.17000000 per share on Jul 15, 2025. The upcoming dividend is slightly lower than the average of the last 10 dividends, which stood at $0.22416667, indicating a modest reduction compared to prior distributions.

Recent developments surrounding EHC highlight both operational and market-related challenges. A critical report recently exposed concerns regarding the company’s care quality, including high patient readmission rates and safety issues, which led to a sharp decline in shares. On July 15, 2025, the stock fell by 10.3% after news of alleged misleading disclosures surfaced. Analysts have since emphasized the importance of selecting experienced counsel for affected investors.

On the operational front, Encompass Health has expanded its national footprint with the opening of its first rehabilitation hospital in Danbury, CT. The facility, which features advanced rehabilitation technologies and 40 private patient rooms, is part of the company’s broader strategy to meet rising demand for inpatient care. This expansion aligns with EHC’s goal to strengthen its network and bring high-quality services closer to patients. The company has also outlined aggressive growth plans for 2025, including the opening of seven new hospitals and the addition of 100-120 beds across existing locations.

Financially, EHC has shown steady revenue growth, with net operating revenues increasing 11.3% year over year to $2.91 billion in the first half of 2025. The company expects full-year revenues to range between $5.88 billion and $5.98 billion. Occupancy rates have also improved, rising to 77.7% in the first half of 2025 from 72.1% in 2023. These metrics suggest that EHC is maintaining a strong market position despite recent volatility.

Keybanc analysts have raised their price target for EHC to $140, reflecting confidence in the company’s long-term growth potential. Meanwhile, hedge funds and institutional investors hold a significant stake in the company, owning 97.25% of its shares. Over the past week, the stock has shown some fluctuation but remains within a broader upward trend, having gained 36% year to date compared to the industry’s 10.6%.

As of late, EHC’s recent expansion in Connecticut and its ongoing hospital development projects have reinforced its position as a key player in the inpatient rehabilitation sector. The company’s focus on enhancing care quality and expanding its network reflects a strategic response to demographic and healthcare trends. With the ex-dividend date approaching on Oct 1, 2025, investors should be aware that any purchase made after this date will not be eligible for the upcoming dividend.